Tissue penetration and exposure of cefepime in patients with diabetic foot infections

Int J Antimicrob Agents. 2016 Mar;47(3):247-8. doi: 10.1016/j.ijantimicag.2016.01.002. Epub 2016 Feb 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cefepime
  • Cephalosporins / pharmacokinetics*
  • Cephalosporins / therapeutic use*
  • Diabetes Mellitus
  • Foot Diseases / drug therapy*
  • Foot Diseases / microbiology
  • Humans
  • Pseudomonas Infections / drug therapy*
  • Pseudomonas Infections / microbiology
  • Pseudomonas aeruginosa / drug effects*

Substances

  • Cephalosporins
  • Cefepime